Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015- NSE Ltd - August 06,2018
August 6, 2018
Corporate Governance Report -Quarter ended June 30,2018- NSE Ltd and BSE Ltd
June 30, 2018
Reconciliation of Share Capital Audit report–quarter ended June 30,2018
June 30, 2018
Unaudited financial results for the three months ended June 30,2018
June 30, 2018
Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015- NSE Ltd, BSE Ltd and Luxembourg Stock exchange - June 25,2018
June 25, 2018
Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015-NSE, BSE and Luxembourg Stock exchange
June 12, 2018
Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015- BSE Ltd- May 14,2018
May 14, 2018
Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015- NSE Ltd- May 14,2018
May 14, 2018
Outcome of meeting – April 17,2018- Luxembourg Stock exchange
April 17, 2018
Outcome of meeting – April 17,2018- BSE Ltd
April 17, 2018
Outcome of meeting – April 17,2018- NSE Ltd
April 17, 2018
Certificate under Regulation 7(3) of the SEBI (LODR) Regulations,2015 – BSE Ltd
April 3, 2018
Certificate under Regulation 7(3) of the SEBI (LODR) Regulations,2015 – NSE Ltd
April 3, 2018
Reconciliation of share capital audit –quarter ended March 31,2018-BSE Ltd
March 31, 2018
Reconciliation of share capital audit –quarter ended March 31,2018-NSE Ltd
March 31, 2018
Certificate under Regulation 40(9) of the SEBI (LODR) Regulations,2015- BSE Ltd – March 31,2018
March 31, 2018
Previous
1
...
Next
30 / 36